[go: up one dir, main page]

RU2019134182A3 - - Google Patents

Download PDF

Info

Publication number
RU2019134182A3
RU2019134182A3 RU2019134182A RU2019134182A RU2019134182A3 RU 2019134182 A3 RU2019134182 A3 RU 2019134182A3 RU 2019134182 A RU2019134182 A RU 2019134182A RU 2019134182 A RU2019134182 A RU 2019134182A RU 2019134182 A3 RU2019134182 A3 RU 2019134182A3
Authority
RU
Russia
Application number
RU2019134182A
Other versions
RU2019134182A (ru
RU2765820C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2019134182A publication Critical patent/RU2019134182A/ru
Publication of RU2019134182A3 publication Critical patent/RU2019134182A3/ru
Application granted granted Critical
Publication of RU2765820C2 publication Critical patent/RU2765820C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2019134182A 2017-03-28 2018-03-26 Новые способы лечения рассеянного склероза RU2765820C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762477717P 2017-03-28 2017-03-28
US62/477,717 2017-03-28
PCT/IB2018/052057 WO2018178852A1 (en) 2017-03-28 2018-03-26 New methods for the treatment of multiple sclerosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2022102195A Division RU2022102195A (ru) 2017-03-28 2018-03-26 Новые способы лечения бокового амиотрофического склероза

Publications (3)

Publication Number Publication Date
RU2019134182A RU2019134182A (ru) 2021-04-28
RU2019134182A3 true RU2019134182A3 (ru) 2021-07-20
RU2765820C2 RU2765820C2 (ru) 2022-02-03

Family

ID=62002180

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2019134182A RU2765820C2 (ru) 2017-03-28 2018-03-26 Новые способы лечения рассеянного склероза
RU2022102195A RU2022102195A (ru) 2017-03-28 2018-03-26 Новые способы лечения бокового амиотрофического склероза

Family Applications After (1)

Application Number Title Priority Date Filing Date
RU2022102195A RU2022102195A (ru) 2017-03-28 2018-03-26 Новые способы лечения бокового амиотрофического склероза

Country Status (13)

Country Link
US (1) US20200093801A1 (ru)
EP (2) EP4324523A3 (ru)
JP (2) JP2020515555A (ru)
KR (1) KR20190128703A (ru)
CN (2) CN110475555A (ru)
AU (1) AU2018242535B2 (ru)
BR (1) BR112019020093A2 (ru)
CA (1) CA3057040A1 (ru)
CL (1) CL2019002704A1 (ru)
IL (1) IL269681A (ru)
MX (1) MX394840B (ru)
RU (2) RU2765820C2 (ru)
WO (1) WO2018178852A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230004635A (ko) * 2020-04-21 2023-01-06 노파르티스 아게 Csf-1r에 의해 조절되는 질병을 치료하기 위한 투여 요법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008013427A (es) 2006-04-19 2008-11-04 Novartis Ag Compuestos de benzoxazole y benzotiazole sustituidos-6-0 y metodos para inhibir la señalizacion csf-1r.
JP2011500635A (ja) * 2007-10-18 2011-01-06 ノバルティス アーゲー 癌および骨疾患の処置のためのcsf−1r阻害剤
WO2012151541A1 (en) * 2011-05-05 2012-11-08 Novartis Ag Csf-1r inhibitors for treatment of brain tumors
US20150119267A1 (en) * 2012-04-16 2015-04-30 Sloan-Kettering Institute For Cancer Research Inhibition of colony stimulating factor-1 receptor signaling for the treatment of brain cancer
CN106659710A (zh) * 2014-05-25 2017-05-10 麦德维尔实验室有限公司 用于治疗多发性硬化的方法
MA47395A (fr) * 2015-05-27 2019-12-11 Ucb Biopharma Sprl Méthode pour le traitement d'une maladie neurologique
NZ740616A (en) * 2015-09-14 2023-05-26 Infinity Pharmaceuticals Inc Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
US10092564B2 (en) * 2016-03-25 2018-10-09 Ab Science Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation

Also Published As

Publication number Publication date
CN116139135A (zh) 2023-05-23
BR112019020093A2 (pt) 2020-04-28
RU2022102195A (ru) 2022-03-05
IL269681A (en) 2019-11-28
KR20190128703A (ko) 2019-11-18
WO2018178852A1 (en) 2018-10-04
CN110475555A (zh) 2019-11-19
AU2018242535A1 (en) 2019-10-03
AU2018242535B2 (en) 2021-01-28
JP2020515555A (ja) 2020-05-28
EP4324523A3 (en) 2024-05-01
EP3600311B1 (en) 2024-05-15
MX394840B (es) 2025-03-24
RU2019134182A (ru) 2021-04-28
US20200093801A1 (en) 2020-03-26
MX2019011547A (es) 2019-11-28
RU2765820C2 (ru) 2022-02-03
CL2019002704A1 (es) 2020-01-10
CA3057040A1 (en) 2018-10-04
EP4324523A2 (en) 2024-02-21
JP2023159125A (ja) 2023-10-31
EP3600311A1 (en) 2020-02-05

Similar Documents

Publication Publication Date Title
BR122021024395A2 (ru)
BR122021000189A2 (ru)
BR112020006084A8 (ru)
BR112019008823A2 (ru)
BR122022025811B8 (ru)
RU2019134182A3 (ru)
BR122021023687A2 (ru)
BR122021014832A2 (ru)
BR122022003522A2 (ru)
BR112020008820A2 (ru)
BR102017023327A2 (ru)
BR102017015495A2 (ru)
BR102017015250A2 (ru)
BR102017014430A2 (ru)
BR202017006953U2 (ru)
BR102017003115A2 (ru)
CN304005202S (ru)
CN303892649S8 (ru)
CN303995006S (ru)
CN303998257S (ru)
CN303991390S (ru)
CN303991351S (ru)
CN304000216S (ru)
CN303952054S8 (ru)
CN303949240S9 (ru)